BRAF Apr 25 2025 FORTE: A Phase 2 Master Protocol Assessing Plixorafenib for BRAF-Altered Cancers Read more
BRAF Oct 17 2024 Safety & Efficacy of BRAF Inhibitor Plixorafenib in Children & Adults with Recurrent, BRAF altered PCNSTs Read more
BRAF Apr 17 2024 Paradox-Breaker BRAF inhibitor plixorafenib (FORE8394) synergizes with MEKi in BRAF V600 and non- V600 alterations Read more
BRAF Apr 17 2024 Safety & Efficacy of BRAF Inhibitor FORE8394 Patients w. Advanced Solid & CNS Tumors Read more
BRAF Apr 16 2024 Dose optimization of novel BRAF inhibitor FORE8394 based on PK and efficacy results Read more
BRAF Aug 15 2020 A systematic analysis of BRAF mutations and their sensitivity to different BRAF inhibitors Read more